Skip to main content

TYVASO is approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

Skip to main content
Hamburger button
Close button


Support while you begin treatment with TYVASO

The United Therapeutics Archways program offers a variety of educational resources including a Virtual Patient Educator, available at no cost for patients and caregivers as you being your treatment journey with Tyvaso.

Once you’ve been prescribed TYVASO, you can enroll in the Archways program online, by phone or by text message. You will be contacted by a United Therapeutics Virtual Patient Educator, and will talk one-on-one via phone or video chat, so you can get answers to questions about:

Disease Information

Details about starting TYVASO

How to use the device

What to expect when getting started in the Specialty Pharmacy process

Get started now.


United Therapeutics and the Archways program do not provide medical advice. You are advised to consult with your Healthcare Provider with any specific questions or concerns about your treatment.